Your browser doesn't support javascript.
loading
CGRP and PTX3 as Predictors of Efficacy of Onabotulinumtoxin Type A in Chronic Migraine: An Observational Study.
Domínguez, Clara; Vieites-Prado, Alba; Pérez-Mato, María; Sobrino, Tomás; Rodríguez-Osorio, Xiana; López, Ana; Campos, Francisco; Martínez, Francisco; Castillo, José; Leira, Rogelio.
Affiliation
  • Domínguez C; Department of Neurology, Hospital Clínico Universitario, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
  • Vieites-Prado A; Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Hospital Clínico Universitario, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
  • Pérez-Mato M; Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Hospital Clínico Universitario, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
  • Sobrino T; Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Hospital Clínico Universitario, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
  • Rodríguez-Osorio X; Department of Neurology, Hospital Clínico Universitario, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
  • López A; Department of Neurology, Hospital Clínico Universitario, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
  • Campos F; Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Hospital Clínico Universitario, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
  • Martínez F; Department of Neurology, Hospital Clínico Universitario, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
  • Castillo J; Clinical Neurosciences Research Laboratory, Health Research Institute of Santiago de Compostela (IDIS), Hospital Clínico Universitario, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
  • Leira R; Department of Neurology, Hospital Clínico Universitario, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.
Headache ; 58(1): 78-87, 2018 Jan.
Article in En | MEDLINE | ID: mdl-29131327
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: C-Reactive Protein / Serum Amyloid P-Component / Calcitonin Gene-Related Peptide / Botulinum Toxins, Type A / Migraine Disorders / Neuromuscular Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Headache Year: 2018 Type: Article Affiliation country: Spain
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: C-Reactive Protein / Serum Amyloid P-Component / Calcitonin Gene-Related Peptide / Botulinum Toxins, Type A / Migraine Disorders / Neuromuscular Agents Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Headache Year: 2018 Type: Article Affiliation country: Spain